SAN FRANCISCO, March 22, 2016 /PRNewswire/ -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, has been named a finalist in the 'Best Sponsor-Focused Technological Development' category for the 2016 Clinical Research & Excellence (CARE) Awards. Activate, a SaaS solution for accelerating site activation, a perpetual bottleneck in starting clinical trials, has been shortlisted for the inaugural awards, which take place in Boston on April 27, 2016.
The CARE Awards provides the industry with an opportunity to acknowledge and applaud its highest achievers across all parts of the value chain, and to recognize both corporate and individual achievement.
Study Startup (SSU) refers to a series of steps performed before a clinical trial begins. These typically include activities such as country selection, pre-study visits, site selection and initiation, regulatory document submission, contract and budget negotiations, and enrolling the first patient. Since each of these steps has multiple components, delays in study timelines are commonplace.
"The CARE Awards' recognition of our software supports our continued efforts, and that of our customers and partners, to advance SSU and we are honored that our technology has been acknowledged among the best solutions in the industry," said Sujay Jadhav, goBalto's CEO.
With recent multiple enterprise expansions goBalto now services more than three-quarters of the top global pharmas and CROs, having the largest industry-proven set of country specific regulatory business process workflows and associated in-depth activation metrics.
"Our nomination is a reflection of our commitment to providing our customers with the functionality they need to accelerate the startup phases of clinical trials, leading to greater cost savings and faster market entry – enabling valuable therapies to get to patients sooner," added Jadhav.
goBalto is the industry leader in cloud-based study startup software for the global life sciences industry. Committed to accelerating clinical trials through innovation, product excellence, and customer success, goBalto works with over half of top 20 Pharma and top 10 CROs. Our customers include: Novartis, Genentech Roche, ICON, INC Research and Covance. goBalto is headquartered in San Francisco, with offices in Pennsylvania and Singapore. For more information, visit www.gobalto.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/gobalto-named-clinical-research-and-excellence-awards-finalist-300238883.html
SOURCE goBalto, Inc.